About the Company
We do not have any company description for SAB Biotherapeutics, Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
SAB Biotherapeutics, Inc. (SABS) is expected to deliver a year-over-year decline in earnings on higher revenues when it ...
SAB Biotherapeutics Announces Q1 2024 Financial ... - Markets Insider
MIAMI, May 20, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunotherapy platform ...
SAB Biotherapeutics Inc Shares Near 52-Week Low - Nasdaq
SAB Biotherapeutics Inc (SABS) shares closed today at 1.0% above its 52 week low of $7.30, giving the company a market cap of $320M. The stock is currently down 5.6% year-to-date, down 27.4% over ...
SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings ... - Nasdaq
SAB Biotherapeutics, Inc. (SABS) is expected to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025.
SAB Biotherapeutics Leads The Pack Of 3 US Penny Stocks To Consider
SAB Biotherapeutics, Inc., with a market cap of US$42.92 million, has faced increasing net losses, reporting a US$10.35 million loss in Q3 2024 compared to US$5.1 million the previous year.
SAB Biotherapeutics Provides SAB-142 Trial Update - Markets Insider
MIAMI BEACH, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB” or the “Company”), a clinical-stage biopharmaceutical company with a novel ...
Here’s Why SAB Biotherapeutics, Inc. (NASDAQ:SABS) Is Among the Best ...
SAB Biotherapeutics, Inc. (NASDAQ:SABS) is gaining attention as a top diabetes stock under $10 which was driven by its innovative lead asset, SAB-142, a disease-modifying therapy for Type 1 ...
SABS - SAB Biotherapeutics Inc Chart | Morningstar
SAB Biotherapeutics Inc SAB Biotherapeutics Inc SABS Stock XNAS Rating as of Jul 3, 2025 Download PDF More Actions ...
SAB Biotherapeutics, Inc. (SABSW) - Yahoo Finance
Get the latest SAB Biotherapeutics, Inc. (SABSW) stock news and headlines to help you in your trading and investing decisions.
SABSW SAB Biotherapeutics, Inc. WT EXP 102226
SAB Biotherapeutics, Inc. WT EXP 102226 SEC Filing - Quarterly Report (10-Q) August 08, 2024 SEC FilingsThu, Aug. 08, 2024 SAB Biotherapeutics rebrands as SAB BIO; reaffirms full-year outlook ...
Similar Companies
Loading the latest forecasts...